Ethereum Price Prediction: Is ETH Headed for $5,000 in the Mid Term?
Ethereum could hit new heights following a surge in activity in the altcoin market, but a BTC correction is looming.
Renowned trader and technical analyst Michael van de Poppe believes altcoins are rising, and Ethereum is set to benefit from the upcoming upswing.
Van de Poppe, who shares insights with his 697,000 followers on X, predicts a surge in the altcoin market, which could lead Ethereum (ETH) to potentially reach $5,000 as investors turn their attention away from Bitcoin towards altcoins.
#Altcoin market capitalization is slowly moving upwards.
The upside could be captured on Bitcoin, meaning a rotation towards altcoins.
Therefore, Ethereum to $4,500-5,000 is likely, while altcoins will accelerate with 2-4x returns. pic.twitter.com/FKEaPpjrZv
— Michaël van de Poppe (@CryptoMichNL) February 29, 2024
It’s worth recalling that layer-2s on Ethereum are experiencing a boom in Total Value Locked, pushing ETH to new peaks. Moreover, it seems the attention is shifting to the possibility of an Ethereum spot ETF by May 2024.
This week, multiple altcoins have exploded in price, especially meme coins like WIF and PEPE. Solana reached an intraday high of $134, gaining over 10% in 24 hours.
Possible Bitcoin Correction?
Regarding Bitcoin, Van de Poppe hinted at a possible correction following the substantial net inflows driven by institutional demand. He pinpoints possible support levels at $46,000 or $53,000.
Poppe is not the only analyst warning about retraces. Daniel Yan, co-founder at Matrixport, warned against a possible correction of 15% by the end of April, which would be around $52,000-$53,000.
Similarly, well-known crypto trader Ali (Ali_Charts on X) reports a notable increase in profit-taking by Bitcoin whales, highlighting that over the past three days, they’ve sold off more than 80,000 BTC, equivalent to around $4.8 billion.
Ali also pointed out that the TD Sequential indicator has signaled a sell on the 4-hour chart for Bitcoin. He notes that since February 15, “every sell signal from this indicator has been spot-on, leading to $BTC price corrections between 1.50% and 4.20%.”
However, only time will tell whether Bitcoin will find and sustain support above $50K or correct below that figure. One thing remains true —Bitcoin and the overall crypto market have had their best month in years, with BTC adding thousands of dollars to its price daily and most altcoins going vertical this week.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Wall Street Stands Guard as Bessent Strikes Again: Aftereffects of August's "Treasury Turnaround" Persist, November Refinancing Notice Could Be the Next Flashpoint
As the US Treasury prepares to update its debt management plan in November, key clues may emerge on Friday.
"Coca-Cola belief" never goes out of style! KFC in America says goodbye to Pepsi and embraces Coca-Cola (KO.US); Buffett-style "boring investment" returns to the spotlight
KFC has chosen Coca-Cola as its soda supplier in the United States, abandoning its long-term partner Pepsi. As of the close of the U.S. stock market on Thursday, Coca-Cola's (KO.US) stock price reached a record high, defying the ongoing declines in global tech stocks, especially in the semiconductor and broad AI computing sectors.
AI financing concerns weigh heavily on chip stocks, global tech sector has lost over $1 trillion this week
Multiple pressures, including rising expectations of a Federal Reserve rate hike and increasing AI financing costs, have led to a massive sell-off in global tech stocks this week. The combined market value of the world's top 20 AI and semiconductor stocks has evaporated by more than $1 trillion, and the semiconductor ETF (SOXX) has recorded its longest losing streak in 11 years. On Thursday, SK Hynix continued to plunge by over 10% in a single day, while Nvidia, Samsung, and SoftBank were not spared.
Safe Haven Amid AI Crash! Major Pharmaceutical Stocks Approach Historic Highs
Amid concerns over AI capital expenditures, funds are seeking a "certainty premium." State Street Healthcare ETF reached a record high. Eli Lilly and AbbVie are both approaching their historical highest closing prices, while Gilead and Amgen have surged 7.7% and 7.2% respectively over the past five days. Eli Lilly continues to bet on the future through its GLP-1 dominance and 40 M&A deals totaling $20 billion. AbbVie's core drug Skyrizi has shown positive data for its new subcutaneous formulation, which is expected to extend its patent and drive additional sales.

